Valmark Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$485K Sell
1,254
-37
-3% -$13.7K 0.01% 505
2026
Q1
$378K Hold
1,291
﹤0.01% 535
2025
Q4
$453K Sell
1,291
-54
-4% -$18.2K 0.01% 463
2025
Q3
$435K Sell
1,345
-162
-11% -$50.4K 0.01% 463
2025
Q2
$586K Buy
1,507
+11
+0.7% +$4.42K 0.01% 421
2025
Q1
$651K Buy
1,496
+101
+7% +$40.5K 0.01% 383
2024
Q4
$514K Sell
1,395
-314
-18% -$131K 0.01% 414
2024
Q3
$889K Sell
1,709
-98
-5% -$52.4K 0.01% 325
2024
Q2
$979K Buy
1,807
+29
+2% +$15.3K 0.02% 290
2024
Q1
$922K Buy
1,778
+249
+16% +$124K 0.02% 281
2023
Q4
$721K Sell
1,529
-59
-4% -$27.3K 0.01% 303
2023
Q3
$691K Buy
1,588
+29
+2% +$13.2K 0.01% 280
2023
Q2
$693K Buy
1,559
+29
+2% +$13.4K 0.01% 282
2023
Q1
$703K Buy
1,530
+708
+86% +$337K 0.02% 267
2022
Q4
$422K Buy
822
+9
+1% +$4.57K 0.01% 330
2022
Q3
$369K Sell
813
-31
-4% -$14.8K 0.01% 320
2022
Q2
$407K Sell
844
-69
-8% -$34.1K 0.01% 315
2022
Q1
$449K Buy
913
+101
+12% +$46.2K 0.01% 315
2021
Q4
$377K Buy
+812
New +$342K 0.01% 316

Other funds holding ELV

Valmark Advisers's ELV Position: Q2 2026 in Review

Valmark Advisers reduced its Elevance Health (ELV) stake by 2.9% in Q2 2026, selling an estimated $13.7K and leaving 1,254 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #505.

Valmark Advisers first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $979K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Valmark Advisers held 1,254 shares of Elevance Health worth $485K as of Q2 2026.
  • Valmark Advisers sold 37 Elevance Health shares in Q2 2026, an estimated $13.7K.
  • Elevance Health made up 0.01% of Valmark Advisers's portfolio in Q2 2026, its #505 holding.
  • Valmark Advisers first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • Valmark Advisers's Elevance Health position peaked at $979K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.